Cargando…
Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
BACKGROUND: Multiple sclerosis is a demyelinating autoimmune disease, for which there is no blood‐borne biomarker. Erythrocytes may provide a source of such biomarkers as they contain microRNAs. MicroRNAs regulate protein translation through complementary binding to messenger RNA. As erythrocytes ar...
Autores principales: | Groen, Kira, Maltby, Vicki E., Scott, Rodney J., Tajouri, Lotti, Lechner‐Scott, Jeannette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240864/ https://www.ncbi.nlm.nih.gov/pubmed/32508012 http://dx.doi.org/10.1002/ctm2.22 |
Ejemplares similares
-
Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis
por: Groen, Kira, et al.
Publicado: (2018) -
Erythrocytes in multiple sclerosis – forgotten contributors to the
pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016) -
Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells
por: Sanders, Katherine A., et al.
Publicado: (2016) -
Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2015) -
Genome-wide DNA methylation changes in CD19(+) B cells from relapsing-remitting multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2018)